Neuroinflammation assays for neurodegenerative disease research are essential tools for studying the role of inflammation in conditions like Alzheimer’s, Parkinson’s, and ALS. These assays measure markers such as cytokines, microglial activation, and oxidative stress in cellular and animal models. By understanding neuroinflammatory mechanisms, researchers can identify potential therapeutic targets and test anti-inflammatory compounds. This approach accelerates the development of treatments to mitigate inflammation-driven neurodegeneration and improve patient outcomes.